Regine Bartsch-Li

Title: Inventor Regine Bartsch-Li: Pioneering Neurological Therapeutics

Introduction: Regine Bartsch-Li, based in Fontenay-aux-Roses, France, is an innovative inventor known for her contributions to the field of pharmaceuticals, particularly in the development of compounds to treat various diseases. Her work focuses on the inhibition of fatty acid amido hydrolase (FAAH), marking significant advancements in the treatment of neurological and inflammatory conditions.

Latest Patents: Regine Bartsch-Li holds a patent for "Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors." This patent describes a series of compounds and compositions aimed at treating neurological diseases associated with neurogenic and neuropathic pain, as well as inflammatory diseases, renal ischemia, and cardiovascular conditions. The compounds outlined in the patent represent a formula involving an alkylene group, with various defined variables enhancing their therapeutic potential.

Career Highlights: Regine Bartsch-Li has played a significant role in pharmaceutical innovation at Sanofi-Aventis, a prominent player in the healthcare industry. Throughout her career, she has focused on utilizing her scientific background to create solutions for complex health issues.

Collaborations: During her tenure at Sanofi-Aventis, Regine has collaborated with distinguished colleagues, including Ahmed Abouabdellah and Christian Hoornaert. These partnerships have enabled the development of innovative approaches to drug formulation and therapeutic strategies.

Conclusion: Regine Bartsch-Li exemplifies the qualities of a forward-thinking inventor dedicated to enhancing healthcare through innovative pharmaceutical solutions. Her patent illustrates her commitment to finding effective treatments for debilitating diseases, making her an invaluable asset to the field of medical research and innovation.